Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center

A magical night of celebration and purpose was held on October 25, 2012, at the CINJ Foundation's Award of Hope Gala that took place at The Palace at Somerset Park. CINJ Foundation Board of Trustees Chair Subha Barry started the evening by welcoming the more than 400 attendees. Lt. Governor Kim Guadagno addressed the room with heartfelt and motivating remarks and called upon CINJ doctors and scientists to work harder each day so that fewer New Jerseyans would be affected by cancer. The Award for Corporate Leadership was presented to PricewaterhouseCoopers and Embrace Kids Foundation received the Award for Philanthropic Leadership. All guests were moved by the tribute video of Dr. Barton Kamen, former Chief of Pediatric Hematology/Oncology at CINJ, who was honored posthumously with the Award of Hope for Leadership in Research and Patient Care. A standing ovation was given to Dr. Kamen's wife, Dr. Ruth Kamen, and daughter, Libby Kamen as they accepted the award on his behalf.View the video

Research from The Cancer Institute of New Jersey shows that women with triple-negative breast cancer and no more than three positive lymph nodes following a mastectomy, have a higher risk of local recurrence than similar women whose disease is not classified as triple-negative. The work was presented as an abstract during the Annual Meeting of the American Society for Radiation Oncology. By further defining the risk of local recurrence, investigators may be better able to determine whether radiation treatment should be part of post-mastectomy therapy.Read more

New Jersey Monthly magazine has named four physician leaders at The Cancer Institute of New Jersey "tops" in its annual Top Doctors issue out this month. David August, MD, chief of surgical oncology; Richard Drachtman, MD, interim chief of pediatric hematology/oncology; Darlene Gibbon, MD, chief of gynecologic oncology; and Lorna Rodriguez, MD, PhD, director of precision medicine, were voted as such by their peers for providing state-of-the-art healthcare and tireless dedication toward their patients.Read more